• Ownership

Matthew Gline - Insider Trading & Ownership

Entity
Individual
Location
C/O Urovant Sciences, Inc., 5151 California Avenue, Suite 250, Irvine, CA
Summary
The estimated net worth of Matthew Gline is at least $317M dollars as of March 24, 2025. Matthew Gline is the CEO, Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $190M. Matthew Gline is the Director, 10%+ Owner of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $128M.
All Insider Reports
All Insider Reports

Ownership of Matthew Gline

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. CEO, Director $190M -$23.4M -11% Mar 20, 2025
ABUS Arbutus Biopharma Corp Director, 10%+ Owner $128M Feb 24, 2025

Insider Transactions Reported by Matthew Gline:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.